

Akashi Therapeutics is a clinical stage biopharmaceutical company.
| Headquarter | 18th Floor Cambridge, MA United States of America |
|---|---|
| Website | akashirx.com |
| Founding Date | 2012 |
| Tel | 617-431-7250 |
| Company Status | Private |
1 employee at Akashi Therapeutics has reviewed Akashi Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was 15 days ago.

The prevailing opinion from Comparably users in Boston about their company is that it was very prepared on their first day. Boston employees concluded that their overall onboarding experience was positive. 75% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Akashi Therapeutics employees have provided insight into whether or not they clearly understand Akashi Therapeutics' KPIs and OKRs.

Marc Blaustein CEO / President
Marc Blaustein serves as the CEO / President of Akashi Therapeutics.

Alka Batycky Chief Operating Officer
Alka Batycky serves as the Chief Operating Officer of Akashi Therapeutics, Inc.. Alka started at Akashi Therapeutics,...

No Recent Jobs found for Akashi Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Akashi Therapeutics address?
Akashi Therapeutics location is at 18th Floor
Who is the CEO of Akashi Therapeutics?
Akashi Therapeutics CEO is Marc Blaustein, their score by employees is 20
What is Akashi Therapeutics eNPS?
The eNPS for Akashi Therapeutics is -100
Who is Akashi Therapeutics leadership?
Alka Batycky are part of Akashi Therapeutics leadership, Marc Blaustein is the CEO